Patrice Ann Duvernay, MD | |
324 10th Ave Ste 200, Salt Lake City, UT 84103-2869 | |
(801) 408-7540 | |
(801) 408-2886 |
Full Name | Patrice Ann Duvernay |
---|---|
Gender | Female |
Speciality | Neurology |
Experience | 35 Years |
Location | 324 10th Ave Ste 200, Salt Lake City, Utah |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073543872 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084N0400X | Psychiatry & Neurology - Neurology | 183098-1205 (Utah) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Intermountain Medical Center | Murray, UT | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Intermountain Healthcare Services, Inc | 1850209420 | 3063 |
News Archive
A team of scientists from the Cancer Science Institute of Singapore at the National University of Singapore and National University Cancer Institute Singapore, and their collaborators from the Cedars-Sinai Medical Centre, UCLA School of Medicine, demonstrated that a number of novel genetic defects are able to induce oesophageal cancer.
U.N. Secretary-General Ban Ki-moon on Thursday at an event hosted by Qatar on the sidelines of the 67th General Assembly meeting "called again for urgent and concrete action on climate change, as high-level officials gathered at the United Nations to discuss the growing global concern over the impacts of the phenomenon on food and water security," the U.N. News Centre reports.
Cempra Pharmaceuticals today announced the successful completion of Phase 1 clinical trials of its oral formulation of CEM-101, which showed good tolerability in those studies. The company also announced plans to submit an IND to the FDA to begin a Phase 1 study with the company's intravenous formulation of CEM-101 in mid-2010.
Human beings are directly responsible for more than 110,000 chemical substances which have been generated since the Industrial Revolution.
› Verified 7 days ago
Entity Name | Ihc Health Services Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1629260880 PECOS PAC ID: 1850209420 Enrollment ID: O20031105000079 |
News Archive
A team of scientists from the Cancer Science Institute of Singapore at the National University of Singapore and National University Cancer Institute Singapore, and their collaborators from the Cedars-Sinai Medical Centre, UCLA School of Medicine, demonstrated that a number of novel genetic defects are able to induce oesophageal cancer.
U.N. Secretary-General Ban Ki-moon on Thursday at an event hosted by Qatar on the sidelines of the 67th General Assembly meeting "called again for urgent and concrete action on climate change, as high-level officials gathered at the United Nations to discuss the growing global concern over the impacts of the phenomenon on food and water security," the U.N. News Centre reports.
Cempra Pharmaceuticals today announced the successful completion of Phase 1 clinical trials of its oral formulation of CEM-101, which showed good tolerability in those studies. The company also announced plans to submit an IND to the FDA to begin a Phase 1 study with the company's intravenous formulation of CEM-101 in mid-2010.
Human beings are directly responsible for more than 110,000 chemical substances which have been generated since the Industrial Revolution.
› Verified 7 days ago
Entity Name | Ihc Health Services Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1942325154 PECOS PAC ID: 1850209420 Enrollment ID: O20080610000303 |
News Archive
A team of scientists from the Cancer Science Institute of Singapore at the National University of Singapore and National University Cancer Institute Singapore, and their collaborators from the Cedars-Sinai Medical Centre, UCLA School of Medicine, demonstrated that a number of novel genetic defects are able to induce oesophageal cancer.
U.N. Secretary-General Ban Ki-moon on Thursday at an event hosted by Qatar on the sidelines of the 67th General Assembly meeting "called again for urgent and concrete action on climate change, as high-level officials gathered at the United Nations to discuss the growing global concern over the impacts of the phenomenon on food and water security," the U.N. News Centre reports.
Cempra Pharmaceuticals today announced the successful completion of Phase 1 clinical trials of its oral formulation of CEM-101, which showed good tolerability in those studies. The company also announced plans to submit an IND to the FDA to begin a Phase 1 study with the company's intravenous formulation of CEM-101 in mid-2010.
Human beings are directly responsible for more than 110,000 chemical substances which have been generated since the Industrial Revolution.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Patrice Ann Duvernay, MD Po Box 27128, Salt Lake City, UT 84127-0128 Ph: (801) 535-8163 | Patrice Ann Duvernay, MD 324 10th Ave Ste 200, Salt Lake City, UT 84103-2869 Ph: (801) 408-7540 |
News Archive
A team of scientists from the Cancer Science Institute of Singapore at the National University of Singapore and National University Cancer Institute Singapore, and their collaborators from the Cedars-Sinai Medical Centre, UCLA School of Medicine, demonstrated that a number of novel genetic defects are able to induce oesophageal cancer.
U.N. Secretary-General Ban Ki-moon on Thursday at an event hosted by Qatar on the sidelines of the 67th General Assembly meeting "called again for urgent and concrete action on climate change, as high-level officials gathered at the United Nations to discuss the growing global concern over the impacts of the phenomenon on food and water security," the U.N. News Centre reports.
Cempra Pharmaceuticals today announced the successful completion of Phase 1 clinical trials of its oral formulation of CEM-101, which showed good tolerability in those studies. The company also announced plans to submit an IND to the FDA to begin a Phase 1 study with the company's intravenous formulation of CEM-101 in mid-2010.
Human beings are directly responsible for more than 110,000 chemical substances which have been generated since the Industrial Revolution.
› Verified 7 days ago
Dr. Eric Thayne Monson, MD, PHD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 501 S Chipeta Way, Salt Lake City, UT 84108 Phone: 801-581-4096 | |
Dr. Gerald Martin Lazar, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2005 E 2700 S, Suite 180, Salt Lake City, UT 84109 Phone: 801-746-2297 Fax: 801-322-3890 | |
Muharrem B. Baytunca, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-581-4096 | |
Leah M. Fortson, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: Huntsman Mental Health Institute, 501 Chipeta Way, Salt Lake City, UT 84108 Phone: 801-581-4096 | |
Norman L. Foster, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-585-6387 | |
Dr. Amy Gallop, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 501 S Chipeta Way, Salt Lake City, UT 84108 Phone: 801-581-2121 | |
Lawrence H Climo, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: Comphealth 4021 South 700 East, Suite 300, Salt Lake City, UT 84107 Phone: 800-453-3030 |